Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort

Journal of the American Geriatrics Society

Volumn 55, Issue 3, 2007, Pages 395-399

  Dartigues, Jean François ^a,b   Carcaillon, Laure ^a,b   Helmer, Catherine ^a,b   Lechevallier, Nathalie ^a,b   Lafuma, Antoine ^c   Khoshnood, Babak ^c  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CEMKA EVAL   (France)

Author keywords

Dementia; Ginkgo biloba; Mortality; Treatment for memory impairment

Indexed keywords

GINKGO BILOBA EXTRACT; NOOTROPIC AGENT; VASODILATOR AGENT;

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MORTALITY; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL;

EID: 33847296631     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01084.x     Document Type: Article

References (24)

1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
2. Jorm AF, Dear KB, Burgess NM. Projections of future numbers of dementia cases in Australia with and without prevention. Aust N Z J Psychiatry 2005;39:959-963.
3. Zandi PP, Anthony JC, Khachaturian AS et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Arch Neurol 2004;61:82-88.
4. Zandi PP, Anthony JC, Hayden KM et al. Reduced incidence of AD with NSAID but not H2 receptor antagonists. The Cache County Study. Neurology 2002;59:880-886.
5. Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer's disease. Neuroepidemiology 2004;23:94-98.
6. Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and incidence of Alzheimer disease in older women. The Cache County Study. JAMA 2002;288:2123-2129.
7. Andrieu S, Gillette S, Amouyal K et al. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. J Gerontol A Biol Sci Med Sci 2003;58A:M372-M377.
8. Brookmeyer R, Corrada MM, Curriero FC et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002;59:1764-1767.
9. Tuokko H, Frerichs R, Graham J et al. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 2003;60:577-582.
10. Slooter AJ, Cruts M, Van Broeckhoven C et al. Apolipoprotein E and longevity: The Rotterdam Study. J Am Geriatr Soc 2001;49:1258-1259.
11. Slooter AJ, Cruts M, Hofman A et al. The impact of APOE on myocardial infarction, stroke, and dementia. The Rotterdam Study. Neurology 2004;62:1196-1198.
12. Dartigues JF, Gagnon M, Barberger-Gateau P et al. The Paquid epidemiological program on brain ageing. Neuroepidemiology 1992;11(Suppl 1):14-18.
13. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. Revised. Washington, DC: American Psychiatric Association, 1987.
15. McKhann G, Drachman D, Folstein M et al. Clinical Diagnosis of Alzheimer's Disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer'sDisease. Neurology 1984;34:939-944.
16. Hachinski VC, Iliff LD, Zilhka E et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
17. Luo Y, Smith JV, Paramasivam V et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 2002;99:12197-12202.
18. Pietri S, Seguin JR, d'Arbigny P et al. Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther 1997;11:121-131.
19. Cox DR. Regression models and life tables (with discussion). J Royal Stat Soc B 1972;74:187-220.
20. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
21. Radloff L. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
22. Fuhrer R, Rouillon F. La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'auto-évaluation. Psychiatr Psychobiol 1989;4:163-166.
23. Le Bars PL, Katz MM, Berman N et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American Egb Study Group. JAMA 1997;278:1327-1332.
24. Ousset PJ, Reynish E, Andrieu S et al. Etude GuidAge (Etude randomisée versus placebo de l'EGb 761 dans la prévention de la maladie d'Alzheimer sur une durée de 5 ans chez 2800 patients). Rationnel Res Prac Alz Dis 2002;6:234-239.